182 related articles for article (PubMed ID: 32013112)
1. Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients.
Hermida M; Cassinotto C; Piron L; Aho-Glélé S; Guillot C; Schembri V; Allimant C; Jaber S; Pageaux GP; Assenat E; Guiu B
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32013112
[TBL] [Abstract][Full Text] [Related]
2. Uni-, Bi- or Trifocal Hepatocellular Carcinoma in Western Patients: Recurrence and Survival after Percutaneous Thermal Ablation.
Preel A; Hermida M; Allimant C; Assenat E; Guillot C; Gozzo C; Aho-Glele S; Pageaux GP; Cassinotto C; Guiu B
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070800
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
4. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.
Yoo J; Lee MW; Lee DH; Lee JH; Han JK
Liver Int; 2020 May; 40(5):1189-1200. PubMed ID: 32056353
[TBL] [Abstract][Full Text] [Related]
7. Four types of tumor progression after microwave ablation of single hepatocellular carcinoma of ≤5 cm: incidence, risk factors and clinical significance.
Huang Z; Guo Z; Ni J; Zuo M; Zhang T; Ma R; An C; Huang J
Int J Hyperthermia; 2021; 38(1):1164-1173. PubMed ID: 34376111
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy.
Hermida M; Cassinotto C; Piron L; Assenat E; Pageaux GP; Escal L; Pierredon-Foulongne MA; Verzilli D; Jaber S; Guiu B
Int J Hyperthermia; 2018 Dec; 35(1):90-96. PubMed ID: 29923441
[TBL] [Abstract][Full Text] [Related]
9. Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.
Hermida M; Preel A; Assenat E; Piron L; Cassinotto C; Ursic-Bedoya J; Guillot C; Herrero A; Panaro F; Pageaux GP; Guiu B
Hepatol Commun; 2021 Apr; 5(4):689-700. PubMed ID: 33860126
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
11. Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocation.
Gozzo C; Hermida M; Herrero A; Panaro F; Cassinotto C; Mohamad AM; Assenat E; Guillot C; Allimant C; Schembri V; Basile A; Dharancy S; Ursic-Bedoya J; Guiu B
Hepatol Commun; 2022 Oct; 6(10):2975-2987. PubMed ID: 35932178
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
13. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
Chinnaratha MA; Sathananthan D; Pateria P; Tse E; MacQuillan G; Mosel L; Pathi R; Madigan D; Wigg AJ
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):349-54. PubMed ID: 25563141
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns.
Xie Y; Lyu T; Guan H; Cao S; Song L; Tong X; Zou Y; Wang J
Front Oncol; 2024; 14():1392495. PubMed ID: 38751809
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
[TBL] [Abstract][Full Text] [Related]
16. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
17. Mid-term outcome of percutaneous thermal ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation.
Shi Y; Chi J; Wang T; Cui D; Tang X; Ding M; Li P; Zhai B
Clin Radiol; 2019 Sep; 74(9):735.e1-735.e7. PubMed ID: 31307766
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study.
Liu B; Long J; Wang W; Huang T; Xie X; Chen S; Huang G; Jiang C; Ye J; Long H; Xie X; Kuang M
BMC Cancer; 2019 Jul; 19(1):699. PubMed ID: 31311502
[TBL] [Abstract][Full Text] [Related]
19. Hepatic resection
Song KD; Lim HK; Rhim H; Lee MW; Kang TW; Paik YH; Kim JM; Joh JW
World J Gastrointest Oncol; 2019 Mar; 11(3):227-237. PubMed ID: 30918595
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival.
Sun Y; Zhang H; Long J; Zhang Y; Zheng J; Yuan C
Front Oncol; 2022; 12():978614. PubMed ID: 36212462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
